TrialInternational journal of gastrointestinal cancer2005

Clinical significance of K-ras and c-erbB-2 mutations in pancreatic adenocarcinoma and chronic pancreatitis.

Renata Talar-Wojnarowska et al.PubMed ↗Publisher ↗

No numbers read from the abstract.